STOCK TITAN
  1. Home
  2. News
  3. CVS

CVS Health Corp - CVS STOCK NEWS

Welcome to our dedicated news page for CVS Health (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on CVS Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CVS Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CVS Health's position in the market.

News
CVS Health to participate at the 45nd Annual Raymond James Institutional Investors Conference
Rhea-AI Summary
CVS Health's CFO Tom Cowhey to participate in fireside chat at Raymond James Institutional Investors Conference on March 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
conferences
-
News
CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
Rhea-AI Summary
CVS Health Corporation (NYSE: CVS) reported strong financial results for the fourth quarter and full year ended December 31, 2023. Total revenues increased to $93.8 billion in the fourth quarter, up 11.9% compared to the prior year, and $357.8 billion for the full year, up 10.9% compared to the prior year. GAAP diluted EPS was $1.58 and Adjusted EPS was $2.12 for the fourth quarter, and $6.47 and $8.74 for the full year, respectively. The company also generated cash flow from operations of $13.4 billion. CVS Health announced a 10% increase in the quarterly shareholder dividend and returned $3.1 billion to shareholders through dividends in 2023. The company's full-year 2024 guidance was revised due to potential implications for elevated medical cost trends in 2024, with revised GAAP diluted EPS guidance to at least $7.06 and Adjusted EPS guidance to at least $8.30, along with revised cash flow from operations guidance to at least $12.0 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.1%
Tags
earnings
-
News
CVS Health adds two new renewable energy projects with Constellation
Rhea-AI Summary
CVS Health has announced two agreements with Constellation to purchase zero-emission, renewable energy equivalent to the annual electricity use of nearly 1,000 CVS Health locations in California, Washington, D.C., Delaware, Maryland, and New Jersey. These investments will reduce the company's carbon footprint by nearly 114,000 metric tons annually. CVS Health's commitment to sustainability is evident through its focus on renewable energy and reducing its environmental impact.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.97%
Tags
none
News
New report from CVS Health® highlights opportunities for the future of community pharmacy
Rhea-AI Summary
CVS Health released a report revealing the critical role of pharmacists in providing healthcare services to patients, emphasizing the need for sustainable and scalable industry-wide change. The report also explores the need for operational improvements, digital innovations, and inspiring more individuals to choose a career in community pharmacy. Key findings from the CVS Health survey show that the majority of Americans prefer pharmacies for their healthcare needs due to their convenient locations and extended hours of operation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none
-
News
CVS Health to Hold Fourth Quarter and Full Year 2023 Earnings Conference Call
Rhea-AI Summary
CVS Health (NYSE: CVS) will hold a conference call to discuss fourth quarter and full year 2023 financial results on February 7, 2024, at 8:00 a.m. ET. The event will be broadcast on the Investor Relations portion of the CVS Health website and archived for a year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3%
Tags
earnings
-
News
CVS Health announces leadership appointments
Rhea-AI Summary
CVS Health (NYSE: CVS) announces leadership updates with Thomas F. Cowhey named as Chief Financial Officer and Mike Pykosz named as President of Health Care Delivery. The company expresses confidence in the new appointments and acknowledges the departure of Shawn Guertin due to family health reasons.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
none
News
CVS Pharmacy® announces new simplified loyalty experience
Rhea-AI Summary
CVS Pharmacy (NYSE: CVS) announces the evolution of its loyalty program to include two membership tiers: ExtraCare and ExtraCare Plus. ExtraCare now offers benefits previously found within the ExtraCare Pharmacy & Health Rewards program, while ExtraCare Plus unlocks all the benefits of ExtraCare, plus the new convenience of free same-day delivery of nearly all products in the store in as little as three hours, and so much more.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
none
-
News
CVS Caremark accelerates biosimilars adoption through formulary changes
Rhea-AI Summary
CVS Health (NYSE: CVS) announces the expansion of biosimilars adoption, removing Humira from major national commercial formularies and covering Humira biosimilars effective April 1, 2024. The U.S. biosimilars market is projected to grow from less than $10 billion in 2022 to more than $100 billion by 2029.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
none
-
News
CVS Health to present at the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
CVS Health (NYSE: CVS) to Participate in Fireside Chat at J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
conferences
News
CVS Health highlights path to accelerating long-term growth through building a world of health around every consumer
Rhea-AI Summary
CVS Health (NYSE: CVS) introduces CVS CostVantageTM and CVS Caremark TrueCostTM to drive aligned incentives and deliver a more transparent and sustainable reimbursement model. The company also launches CVS HealthspireTM brand for Health Services segment, reiterates 2023 financial guidance, and initiates 2024 projections, outlining achievable long-term growth expectations with clear opportunities to outperform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.71%
Tags
none
Stock CVS logo
CVS Health Corp

NYSE:CVS

CVS Rankings

#135 Ranked by Market Cap
#3858 Ranked by Stock Gains
#861 Ranked by Dividends

CVS Stock Data

86.52B
1.25B
0.12%
82.88%
1.8%
Pharmacies and Drug Stores
Retail Trade
Link
US
Woonsocket

About CVS

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.